Kura Oncology

Kura Oncology KURA Stock

$7.56   0.934582%
Add to favorites
Market Cap
$694.60M
LOW - HIGH [24H]
$7.45 - $8.18
VOLUME [24H]
$1.12M
P/E Ratio
0
Earnings per share
-$3.30
ISIN
US50127T1097
Price   Prediction

Kura Oncology Price Chart

Sorry, that's all we've gotfor now...

Kura Oncology (KURA) stock price today is 7.56 USD on Tech Market Large (+0.93% on the day). Updated .

Kura Oncology KURA Financial and Trading Overview

Kura Oncology stock price 7.56 USD
Previous Close 7.49 USD
Open 7.49 USD
Bid 5.77 USD x 200
Ask 10 USD x 400
Day's Range 7.45 - 8.18 USD
52 Week Range 6.75 - 13.9 USD
Volume 757.24K USD
Avg. Volume 2.13M USD
Market Cap 737.79M USD
Beta (5Y Monthly) 0.532
PE Ratio (TTM) N/A
EPS (TTM) -3.3 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 32 USD

KURA Valuation Measures

Enterprise Value 221.91M USD
Trailing P/E N/A
Forward P/E -3.3615482
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 9.30209
Price/Book (mrq) 41.17949
Enterprise Value/Revenue 2.798
Enterprise Value/EBITDA -0.713

Trading Information

Kura Oncology Stock Price History

Beta (5Y Monthly) 0.532
52-Week Change -33.83%
S&P500 52-Week Change 10.51%
52 Week High 13.9 USD
52 Week Low 6.75 USD
50-Day Moving Average 9.95 USD
200-Day Moving Average 9.77 USD

KURA Share Statistics

Avg. Volume (3 month) 2.13M USD
Avg. Daily Volume (10-Days) 3.4M USD
Shares Outstanding 91.88M
Float 73.45M
Short Ratio 7.57
% Held by Insiders 1.57%
% Held by Institutions 97.23%
Shares Short 12.64M
Short % of Float 14.10%
Short % of Shares Outstanding 13.75%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) -394.31%
Gross Margin -227.020%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -32.15%
Return on Equity (ttm) -224.85%

Income Statement

Revenue (ttm) 79.31M USD
Revenue Per Share (ttm) 0.89 USD
Quarterly Revenue Growth (yoy) 10.10%
Gross Profit (ttm) -180059008 USD
EBITDA -311295008 USD
Net Income Avi to Common (ttm) -292873984 USD
Diluted EPS (ttm) -3.3
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 492.1M USD
Total Cash Per Share (mrq) 5.36 USD
Total Debt (mrq) 25.83M USD
Total Debt/Equity (mrq) 143.82 USD
Current Ratio (mrq) 3.595
Book Value Per Share (mrq) 0.195

Cash Flow Statement

Operating Cash Flow (ttm) -85574000 USD
Levered Free Cash Flow (ttm) -111096000 USD

Profile of Kura Oncology

Country United States
State CA
City San Diego
Address 4930 Directors Place
ZIP 92121
Phone 858 500 8800
Website https://www.kuraoncology.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 260

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.

Q&A For Kura Oncology Stock

What is a current KURA stock price?

Kura Oncology KURA stock price today per share is 7.56 USD.

How to purchase Kura Oncology stock?

You can buy KURA shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Kura Oncology?

The stock symbol or ticker of Kura Oncology is KURA.

Which industry does the Kura Oncology company belong to?

The Kura Oncology industry is Biotechnology.

How many shares does Kura Oncology have in circulation?

The max supply of Kura Oncology shares is 91.88M.

What is Kura Oncology Price to Earnings Ratio (PE Ratio)?

Kura Oncology PE Ratio is now.

What was Kura Oncology earnings per share over the trailing 12 months (TTM)?

Kura Oncology EPS is -3.3 USD over the trailing 12 months.

Which sector does the Kura Oncology company belong to?

The Kura Oncology sector is Healthcare.

Kura Oncology KURA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24341.53 USD —
+0.05
3B USD — 24235.01 USD — 24538.78 USD — — 3B USD —
us US Tech Biotechnology NBI US 6982.34 USD —
-0.51
— — 6959.96 USD — 7076.43 USD — — — —
us US Tech Health Care IXHC US 1326.68 USD —
-0.47
— — 1322.85 USD — 1342.46 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
us US Tech Global Select Market Com NQGS US 11990.76 USD —
+0.05
— — 11938.04 USD — 12087.35 USD — — — —
$2.16T
Total marketcap
$68.32B
Total volume
BTC 58.05%   •   ETH 9.90%
Dominance
Select currency